What is the recommended management for a 52-year-old patient whose mother died of a ruptured intracranial aneurysm?

Management of a 52-Year-Old Patient with Maternal History of Fatal Ruptured Intracranial Aneurysm

This patient should undergo screening with MRA or CTA for unruptured intracranial aneurysms given the first-degree family history of aneurysmal subarachnoid hemorrhage, particularly if additional risk factors are present. 1

Risk Assessment

This patient has significantly elevated risk for harboring an unruptured intracranial aneurysm (UIA):

• First-degree relatives of patients with ruptured aneurysms have a 4% prevalence of UIAs (95% CI, 2.6%–5.8%) on screening imaging. 1
• The prevalence ratio for first-degree relatives ranges from 1.9% to 5.9% compared to the general population. 1
• Risk increases substantially when combined with modifiable factors: smoking, hypertension, older age (this patient is 52), female sex, higher lipid levels, or elevated fasting glucose. 1

Screening Recommendation Algorithm

Proceed with screening if:

• Patient has ≥1 additional risk factor beyond family history (smoking, hypertension, hyperlipidemia, diabetes) 1
• Patient is willing to undergo treatment if an aneurysm is discovered 1
• Life expectancy and quality of life would justify potential intervention 1

Screening modality: MRA or CTA (non-invasive imaging) 1

Screening should occur at a center consulting >100 UIA patients per year with multidisciplinary expertise (neurosurgery, neuroradiology, neurology). 2

If Screening is Positive (Aneurysm Detected)

Treatment decision based on 5-year rupture risk versus treatment risk:

• Consider preventive occlusion when estimated 5-year rupture risk exceeds the risk of preventive treatment. 2
• Key rupture risk factors include: aneurysm size, location, morphology, and patient-specific factors 1
• Treatment should only be performed at centers treating >30 aneurysm patients per year per neurosurgeon or neurointerventionalist. 2

Treatment options:

• Neither endovascular nor microsurgical treatment is universally superior; choice depends on aneurysm location, size, patient age, and center expertise 1, 2
• For patients >60 years old, endovascular coiling generally has lower perioperative morbidity than microsurgical clipping. 1

If Screening is Negative

Serial follow-up imaging is reasonable even after negative initial screening:

• In long-term studies, aneurysms were detected in 11% at first screening, 8% at second screening, 5% at third screening, and 5% at fourth screening over 10 years. 1
• This indicates substantial ongoing risk even after initial negative screening. 1

Risk Factor Modification (Regardless of Screening Results)

Mandatory interventions:

• Smoking cessation (strongest modifiable risk factor) 1, 2
• Blood pressure control/treatment of hypertension 1, 2

Not recommended specifically for aneurysm rupture prevention:

• Statins are not recommended with the indication to reduce rupture risk 2
• Aspirin is not recommended with the indication to reduce rupture risk 2

Critical Pitfalls to Avoid

• Do not screen if the patient would not be a candidate for treatment due to severe comorbidities or limited life expectancy. 1
• Do not assume a single negative screening eliminates future risk—serial imaging may be warranted depending on additional risk factors. 1
• Avoid treatment at low-volume centers (<20 cases annually) where outcomes are inferior; referral to high-volume centers is essential. 1, 2